IVERIC Bio Performance
| ISEEDelisted Stock | USD 39.95 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.16, which attests to not very significant fluctuations relative to the market. As returns on the market increase, IVERIC Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding IVERIC Bio is expected to be smaller as well. IVERIC Bio currently retains a risk of 0.0%. Please check out IVERIC Bio maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to decide if IVERIC Bio will be following its current trending patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days IVERIC Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, IVERIC Bio is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 261.4 M | |
| Total Cashflows From Investing Activities | -50.3 M |
IVERIC |
IVERIC Bio Relative Risk vs. Return Landscape
If you would invest 3,995 in IVERIC Bio on September 3, 2024 and sell it today you would earn a total of 0.00 from holding IVERIC Bio or generate 0.0% return on investment over 90 days. IVERIC Bio is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than IVERIC, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
IVERIC Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for IVERIC Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as IVERIC Bio, and traders can use it to determine the average amount a IVERIC Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ISEE |
Based on monthly moving average IVERIC Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IVERIC Bio by adding IVERIC Bio to a well-diversified portfolio.
IVERIC Bio Fundamentals Growth
IVERIC Stock prices reflect investors' perceptions of the future prospects and financial health of IVERIC Bio, and IVERIC Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IVERIC Stock performance.
| Return On Equity | -0.55 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | 4.98 B | |||
| Shares Outstanding | 137.98 M | |||
| Price To Earning | 4.17 X | |||
| Price To Book | 3.81 X | |||
| EBITDA | (192.28 M) | |||
| Cash And Equivalents | 311.96 M | |||
| Cash Per Share | 2.64 X | |||
| Total Debt | 97.77 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 3.48 X | |||
| Cash Flow From Operations | (163.77 M) | |||
| Earnings Per Share | (1.82) X | |||
| Total Asset | 666.82 M | |||
| Retained Earnings | (864.81 M) | |||
| Current Asset | 121.07 M | |||
| Current Liabilities | 14.54 M | |||
About IVERIC Bio Performance
By analyzing IVERIC Bio's fundamental ratios, stakeholders can gain valuable insights into IVERIC Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if IVERIC Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if IVERIC Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases . The company was incorporated in 2007 and is based in Parsippany, New Jersey. Iveric Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.Things to note about IVERIC Bio performance evaluation
Checking the ongoing alerts about IVERIC Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IVERIC Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| IVERIC Bio is not yet fully synchronised with the market data | |
| IVERIC Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (185.21 M) with loss before overhead, payroll, taxes, and interest of (117.01 M). | |
| IVERIC Bio currently holds about 311.96 M in cash with (163.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64. | |
| Over 99.0% of the company shares are owned by institutional investors |
- Analyzing IVERIC Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IVERIC Bio's stock is overvalued or undervalued compared to its peers.
- Examining IVERIC Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating IVERIC Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of IVERIC Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of IVERIC Bio's stock. These opinions can provide insight into IVERIC Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in IVERIC Stock
If you are still planning to invest in IVERIC Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IVERIC Bio's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |